Less than 1% of those in low income countries are fully vaccinated, and that number only rises to 10% in low-middle income countries. Meanwhile more than half of the population in wealthier countries have received a double dose with several now rolling out third doses.
In this episode of Coronapod we look at the role of pharmaceutical manufacturers. Drug companies are facing increased pressure to partner with manufacturing firms in the global south but most are reluctant to relinquish control. We ask what needs to change to help address the global disparity in vaccine access.
News: The fight to manufacture COVID vaccines in lower-income countries
Never miss an episode: Subscribe to the Nature Podcast on Apple Podcasts, Google Podcasts, Spotify or your favourite podcast app. Head here for the Nature Podcast RSS feed.
To remedy health disparities, more scientists must ‘get political’
COVID vaccine boosters: the most important questions
A patent waiver on COVID vaccines is right and fair
